FDA Updates in Endocrinology

Basaglar Wins FDA Approval - FDA alert.

FDA Eliminates REMS for Rosiglitazone-Containing Diabetes Medicines - FDA alert.

FDA Advisory Panel Against Expanded Indications for Ezetimibe - FDA alert. IMPROVE-IT trial.

FDA Updates of SGLT2 Inhibitors Labels - FDA alert.

FDA Approves Kanuma - FDA alert.

FDA Warns of Rare Cases of Underactive Thyroid in Infants - FDA alert.